» Articles » PMID: 20053954

Detergent-resistant Microdomains Determine the Localization of Sigma-1 Receptors to the Endoplasmic Reticulum-mitochondria Junction

Overview
Journal Mol Pharmacol
Date 2010 Jan 8
PMID 20053954
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Sigma-1 receptors (Sig-1Rs) that bind diverse synthetic and endogenous compounds have been implicated in the pathophysiology of several human diseases such as drug addiction, depression, neurodegenerative disorders, pain-related disorders, and cancer. Sig-1Rs were identified recently as novel ligand-operated molecular chaperones. Although Sig-1Rs are predominantly expressed at endoplasmic reticulum (ER) subdomains apposing mitochondria [i.e., the mitochondria-associated ER membrane (MAM)], they dynamically change the cellular distribution, thus regulating both MAM-specific and plasma membrane proteins. However, what determines the location of Sig-1R at the MAM and how the receptor translocation is initiated is unknown. Here we report that the detergent-resistant membranes (DRMs) play an important role in anchoring Sig-1Rs to the MAM. The MAM, which is highly capable of accumulating ceramides, is enriched with both cholesterol and simple sphingolipids, thus forming Triton X-114-resistant DRMs. Sig-1Rs associate with MAM-derived DRMs but not with those from microsomes. A lipid overlay assay found that solubilized Sig-1Rs preferentially associate with simple sphingolipids such as ceramides. Disrupting DRMs by lowering cholesterol or inhibiting de novo synthesis of ceramides at the ER largely decreases Sig-1R at DRMs and causes translocation of Sig-1R from the MAM to ER cisternae. These findings suggest that the MAM, bearing cholesterol and ceramide-enriched microdomains at the ER, may use the microdomains to anchor Sig-1Rs to the location; thus, it serves to stage Sig-1R at ER-mitochondria junctions.

Citing Articles

Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders.

Shokr M, Badawi G, Elshazly S, Zaki H, Mohamed A ACS Pharmacol Transl Sci. 2025; 8(1):47-65.

PMID: 39816800 PMC: 11729429. DOI: 10.1021/acsptsci.4c00564.


Microarray-Based Methodology for Lipid Profiling, Enzymatic Activity, And Binding Assays in Printed Lipid Raft Membranes from Astrocytes and Neurons.

Sanchez-Sanchez L, Fernandez R, Astigarraga E, Barreda-Gomez G, Ganfornina M Anal Chem. 2024; 97(1):86-95.

PMID: 39718364 PMC: 11740170. DOI: 10.1021/acs.analchem.4c02421.


Mitochondrial dysfunction in Parkinson's disease.

Hattori N, Sato S J Neural Transm (Vienna). 2024; 131(12):1415-1428.

PMID: 39585446 DOI: 10.1007/s00702-024-02863-2.


Exploring the Role of Sigma Receptors in the Treatment of Cancer: A Narrative Review.

Fotakopoulos G, Gatos C, Georgakopoulou V, Christodoulidis G, Kagkouras I, Trakas N Cureus. 2024; 16(10):e70946.

PMID: 39502961 PMC: 11537387. DOI: 10.7759/cureus.70946.


Partitioning into ER membrane microdomains impacts autophagic protein turnover during cellular aging.

Prokisch S, Buttner S Sci Rep. 2024; 14(1):13653.

PMID: 38871812 PMC: 11176346. DOI: 10.1038/s41598-024-64493-8.


References
1.
Nuwayhid S, Werling L . Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C. J Pharmacol Exp Ther. 2002; 304(1):364-9. DOI: 10.1124/jpet.102.043398. View

2.
Naslavsky N, Shmeeda H, Friedlander G, Yanai A, Futerman A, Barenholz Y . Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J Biol Chem. 1999; 274(30):20763-71. DOI: 10.1074/jbc.274.30.20763. View

3.
Hayashi T, Su T . Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther. 2003; 306(2):726-33. DOI: 10.1124/jpet.103.051292. View

4.
van Meer G, Wolthoorn J, Degroote S . The fate and function of glycosphingolipid glucosylceramide. Philos Trans R Soc Lond B Biol Sci. 2003; 358(1433):869-73. PMC: 1693184. DOI: 10.1098/rstb.2003.1266. View

5.
Maurice T, Martin-Fardon R, Romieu P, Matsumoto R . Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev. 2002; 26(4):499-527. DOI: 10.1016/s0149-7634(02)00017-9. View